✦ LIBER ✦

Autologous Tunica Vaginalis and Subcapsular Orchiectomy: A Hormonal Therapy for Prostate Cancer

✍ Scribed by Martyn A. Vickers Jr; Donald P. Lamontagne; Khurshid A. Guru; Ramgopal K. Satyanarayana; Kristin E. Vickers; Mani Menon

Book ID: 118761433
Publisher: American Society of Andrology
Year: 2004
Tongue: English
Weight: 135 KB
Volume: 25
Category: Article
ISSN: 1939-4640
DOI: 10.1002/j.1939-4640.2004.tb02803.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Upfront hormonal therapy, radical prosta

Upfront hormonal therapy, radical prostatectomy, and radiation therapy for locally invasive prostate cancer

✍ Wajsman, Zev; Cofrin, David A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A New Hormonal Therapy for Prostatic Can

A New Hormonal Therapy for Prostatic Cancer: Long-term Clinical and Hormonal Response

✍ S. R. AHMED; J. B. F. GRANT; S. M. SHALET; A. HOWELL; C. B. COSTELLO; T. WEATHER 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Combined hormonal and radiation therapy

Combined hormonal and radiation therapy for lymph node-positive prostate cancer

✍ Richard Whittington; S. Bruce Malkowicz; Margaret M. Barnes; Gregory A. Broderic 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Complementary therapies for reducing the

Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research

✍ Mark A Moyad 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

ORCHIECTOMY AND ORCHIECTOMY PLUS MITOMYC

ORCHIECTOMY AND ORCHIECTOMY PLUS MITOMYCIN C FOR METASTATIC PROSTATE CANCER IN PATIENTS WITH POOR PROGNOSIS: THE FINAL RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH IN CANCER THERAPY GENITOURINARY GROUP TRIAL

✍ de Reijke, THEO M.; Keuppens, Frans I.; Whelan, Peter; Kliment, Jan; Robinson, M 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 805 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could